Brief: China Regenerative Medicine International Appoints Wang Xuejun As CEO
31/08/2018 16:04
Aug 31 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* WANG XUEJUN HAS BEEN APPOINTED AS AN EXECUTIVE DIRECTOR,
CHIEF
EXECUTIVE OFFICER
* SHAN YONG HAS BEEN APPOINTED AS VICE PRESIDENT OF COMPANY
Source text for Eikon: ID:nHKS3mRpk
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital